Myofedrin (BioDeep_00000181158)
human metabolite blood metabolite
代谢物信息卡片
化学式: C19H23NO3 (313.1678)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: CC(C(C1=CC=CC=C1)O)NCCC(=O)C2=CC(=CC=C2)OC
InChI: InChI=1S/C19H23NO3/c1-14(19(22)15-7-4-3-5-8-15)20-12-11-18(21)16-9-6-10-17(13-16)23-2/h3-10,13-14,19-20,22H,11-12H2,1-2H3
描述信息
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists
D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
D020011 - Protective Agents > D002316 - Cardiotonic Agents
同义名列表
数据库引用编号
5 个数据库交叉引用编号
- PubChem: 27454
- HMDB: HMDB0254976
- ChEMBL: CHEMBL1094314
- MeSH: Oxyfedrine
- chemspider: 25548
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
亚细胞结构定位 | 关联基因列表 |
---|
文献列表
- Yuji Otsuki, Juntaro Yamasaki, Kentaro Suina, Shogo Okazaki, Naoyoshi Koike, Hideyuki Saya, Osamu Nagano. Vasodilator oxyfedrine inhibits aldehyde metabolism and thereby sensitizes cancer cells to xCT-targeted therapy.
Cancer science.
2020 Jan; 111(1):127-136. doi:
10.1111/cas.14224
. [PMID: 31692172] - Shamsul Hayat, Gulshan Khalique, Mohammad Irfan, Arif Shafi Wani, Bhumi Nath Tripathi, Aqil Ahmad. Physiological changes induced by chromium stress in plants: an overview.
Protoplasma.
2012 Jul; 249(3):599-611. doi:
10.1007/s00709-011-0331-0
. [PMID: 22002742] - P Kh Dzhanashiya, O V Vladytskaya, N V Salibegashvili. Efficiency and mechanisms of the antioxidant effect of standard therapy and refracterin in the treatment of chronic heart failure in elderly patients with postinfarction cardiosclerosis.
Bulletin of experimental biology and medicine.
2004 Oct; 138(4):412-4. doi:
10.1007/s10517-005-0056-1
. [PMID: 15665959] - Y Z Qu, Y E Wang, X X Li. Effects of thiofedrine on platelet aggregation, thromboxane B2 and 6-keto-PGF1 alpha in rats.
Methods and findings in experimental and clinical pharmacology.
1996 Jun; 18(5):297-300. doi:
NULL
. [PMID: 8817463] - N Wetzelsberger, M Birkel, H Fuder, P W Lücker, S Stiegler, S Scheithauer, D Thümmler. Relative bioavailability of DL-oxyfedrine HCl after single-dose oral administration of tablets as compared to equimolar solutions.
Methods and findings in experimental and clinical pharmacology.
1995 Apr; 17(3):185-91. doi:
NULL
. [PMID: 8531509] - J Yu, X X Li. [Effects of oxyfedrine on high blood viscosity and myocardial necrosis induced by epinephrine and ice water stress in rats].
Zhongguo yao li xue bao = Acta pharmacologica Sinica.
1993 Jul; 14(4):364-6. doi:
NULL
. [PMID: 8249637] - S D Seth, M P Gupta, M Gupta, S C Manchanda. Oxyfedrine and propranolol. A comparative experimental approach to protect myocardium against isoprenaline-induced myocardial necrosis.
Arzneimittel-Forschung.
1984; 34(6):678-83. doi:
NULL
. [PMID: 6541488] - P F Litvitskiĭ, Kogan AKn, A N Kudrin, L O Luk'ianova, L I Ol'binskaia. [Use of the inhibition of myocardial lipid peroxidation for use therapy and prevention of experimental transitory coronary failure].
Kardiologiia.
1982; 22(7):94-8. doi:
"
. [PMID: 7109455] - P F Litvitskiĭ, A Kh Kogan, A N Kudrin, L O Luk'ianova, L I Ol'binskaia. [Suppression of myocardial lipid peroxidation during preventive treatment of transitory coronary insufficiency with myophedrine].
Farmakologiia i toksikologiia.
1981 May; 44(3):303-7. doi:
"
. [PMID: 7286187] - J Bonelli, K Hruby, D Magometschnigg, G Hitzenberger, G Kaik. The bio-availability of beta-acetyldigoxine (Novodigal) alone and combined with oxyfedrine (Ildamen-Novodigal).
International journal of clinical pharmacology and biopharmacy.
1977 Jun; 15(6):288-93. doi:
NULL
. [PMID: 881282] - W Förster, H U Block. [The effect of oxyfedrin and prenylamine on the biosynthesis of prostaglandin E2 and F2alpha in the rabbit kidney medulla homogenate].
Acta biologica et medica Germanica.
1976; 35(1):121-2. doi:
NULL
. [PMID: 983597] - W G Nayler, W Burian. The plasma membrane in cardiomyopathy.
Postgraduate medical journal.
1975 May; 51(595):350-6. doi:
10.1136/pgmj.51.595.350
. [PMID: 1215249] - E Appel, G Planz, D Palm, H Grobecker, D Stratmann, M Donike. Excretion of norephedrine by man after oral administration of oxyfedrine.
European journal of clinical pharmacology.
1975 Apr; 8(3-4):161-6. doi:
10.1007/bf00567109
. [PMID: 1233214] - W Urbaszek, G Heiland, H Pankau, D Modersohn. [Influence of coronary-effective substances on the concentration of nonesterified fatty acids in the serum of patients with angina pectoris].
Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete.
1975 Jan; 30(1):15-8. doi:
NULL
. [PMID: 1224707]